Oyin Alao, MPH

Oyin Alao is a Biomedical Research Associate at Reboot Rx, where she analyzes clinical studies, leads expert discussions, and evaluates drug discoveries to advance data-driven cancer treatment strategies. Since joining Reboot Rx in 2024, she has played a key role in informing approaches aimed at improving patient outcomes.

Oyin has co-authored multiple research publications, including work expanding the clinical and genomic landscape of metastatic breast cancer, as well as several pediatric oncology studies conducted through Emory University and CHOA.

Prior to Reboot Rx, Oyin worked at the Broad Institute of MIT and Harvard on the Count Me In initiative, where she supported efforts to accelerate cancer research through patient-partnered data sharing. She also contributed to pediatric oncology research as part of the Pediatric Leukemia and Lymphoma team at Children’s Healthcare of Atlanta. She holds a Master of Public Health in Health Policy and Management from Emory University and a Bachelor of Science in Biochemistry from Northeastern University. Oyin is passionate about advancing equitable access to care and using research to empower patients and improve outcomes.